Levoxigram (Levofloxacin)

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By binding to these targets, it prevents DNA supercoiling and strand separation, leading to bacterial cell death. This mechanism gives it activity against a broad spectrum of Gram‑positive and Gram‑negative organisms.

The exact dose of Levoxigram is set by the prescribing clinician based on the infection type, severity, patient weight, renal function, and local resistance patterns. Dosage may be adjusted for impaired kidney function or specific patient populations, and the prescriber will follow approved labeling guidelines.

Levofloxacin is generally classified as contraindicated in pregnancy and should be avoided unless the potential benefit outweighs the risk to the fetus. It is also not recommended during breastfeeding because it can be excreted in milk. Clinicians should consider alternative agents when treating pregnant or lactating patients.

To request Levoxigram, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Levoxigram (levofloxacin) is a third‑generation fluoroquinolone with a broad spectrum covering many respiratory and urinary pathogens. Compared with older agents like ciprofloxacin, it offers enhanced activity against Streptococcus pneumoniae and better lung penetration, often allowing once‑daily dosing. However, safety considerations such as tendon risk are similar across the class.

Levoxigram tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack or container, protect from moisture, heat, and direct sunlight. Do not store in bathrooms or near sources of humidity to maintain product stability.

Levoxigram is taken orally, usually with a full glass of water. It can be taken with or without food, but antacids containing aluminum or magnesium should be spaced at least two hours apart to avoid reduced absorption. Patients should follow the prescriber’s instructions regarding timing and duration of therapy.

Serious adverse events include tendon rupture (especially the Achilles tendon), QT interval prolongation leading to arrhythmias, severe hypersensitivity reactions such as Stevens‑Johnson syndrome, central nervous system effects like seizures, and hepatic injury. Patients should seek immediate medical attention if they experience sudden tendon pain, palpitations, rash, or neurological symptoms.

Levoxigram should be avoided in individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, patients with prolonged QT interval, and patients taking medications that significantly increase the risk of tendon injury. Caution is also advised for those with severe renal impairment.